Two years after the approval of Fiasp faster-acting insulin in adults, Novo Nordisk has announced the FDA approval of Fi…
Insulin
T1International’s Report on Insulin Prices Around the World
In a time when the insulin price crisis in America has become a such prominent news story, it’s easy to lose sight of th…
Robin Cressman wants to Liberate Insulin
On June 13, the New York Times published a video op-ed with a stark title: “We Either Buy Insulin or We Die.” The video …
Lilly to Introduce Lispro, a Lower-Priced Authorized Generic Humalog
Eli Lilly and Company has announced it would introduce a lower-priced version of Humalog® (insulin lispro injection 100 …
Why Do Long and Short Acting Insulin Pens Look Nearly Identical?
On the top Tresiba long-acting basal insulin, in the middle old Fiasp and on the bottom new Fiasp ultra-rapid insulin
…
8 Reasons Why Insulin is so Outrageously Expensive
This story was co-written by James Elliott and Elizabeth Pfiester. It originally appeared on T1International.
Why does …
Smart Insulin Pens For Today And The Future
When NovoPen by Novo Nordisk hit the market back in 1985, this first FDA approved insulin pen changed the way millions o…
Why is Insulin So Expensive in America?
I was stuck for many years pushing paperwork in a miserable job that I hated. Why did I stay? Because I needed insurance…
Beyond Pump Systems: The Case for Insulin Pens
Medical Innovations Must Benefit All, Not Some.
I’ve been living with Type 1 diabetes for more than 30 years, and I have…
How Close are Researchers to Developing Insulin that Doesn’t Need Refrigeration?
While many diabetes researchers are focusing on treatments and possible cures using nanotechnology, implantable devices,…